AANA Hip Arthroscopy - September 2024-New Cartilage Technologies in 2020_ Ready for Prime Time

Video Transcription

Video Summary

This talk discusses advancements in hip cartilage repair technologies as of 2020, focusing on challenges distinct from knee cartilage repair due to anatomical and biomechanical differences. Cartilage failure often results from trauma, aging, or joint abnormalities like FAI and dysplasia. The goal is to restore hyaline cartilage with type II collagen, maintaining functional cells and extracellular matrix. Treatment options vary by lesion size and location: arthroscopic methods (microfracture, autologous matrix-induced chondrogenesis (AMIC)) suit acetabular defects, while femoral head lesions often require open surgical hip dislocation for techniques like osteochondral grafting or autologous chondrocyte implantation (ACI). Innovations include scaffold augmentations, biologic adjuncts (PRP, growth factors), and next-generation marrow stimulation techniques to improve repair quality and durability. European research leads in novel scaffold and injectable hydrogel developments, reflecting regulatory differences. Overall, success depends on lesion containment and minimal osteoarthritis, with ongoing research needed to tailor methods specific to hip cartilage biology and mechanics for improved long-term outcomes.

Keywords

hip cartilage repair

arthroscopic microfracture

autologous matrix-induced chondrogenesis

osteochondral grafting

biologic adjuncts